Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Snowsill, T."" wg kryterium: Autor


Tytuł :
The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Autorzy :
Ryan NAJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
McMahon R; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Tobi S; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Snowsill T; Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, Devon, United Kingdom.
Esquibel S; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Wallace AJ; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Bunstone S; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Bowers N; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Mosneag IE; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Kitson SJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
O'Flynn H; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Ramchander NC; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Sivalingam VN; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Frayling IM; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, Cardiff University, Cardiff, United Kingdom.
Bolton J; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
McVey RJ; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Evans DG; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Department of Obstetrics and Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2020 Sep 17; Vol. 17 (9), pp. e1003263. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Early Detection of Cancer/*methods
Endometrial Neoplasms/*genetics
Adult ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis/pathology ; Cross-Sectional Studies ; DNA Methylation/genetics ; DNA Mismatch Repair/genetics ; Endometrial Neoplasms/diagnosis ; Female ; Genetic Testing/methods ; Humans ; Immunohistochemistry ; Mass Screening/methods ; Microsatellite Instability ; Middle Aged ; Prospective Studies ; Sensitivity and Specificity ; United Kingdom
Czasopismo naukowe
Tytuł :
Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants.
Autorzy :
Caswell RC; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Snowsill T; Institute of Health Research, University of Exeter Medical School, Exeter, UK.
Houghton JAL; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Chakera AJ; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Shepherd MH; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Laver TW; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
Knight BA; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Wright D; Institute of Health Research, University of Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, UK.
Hattersley AT; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Ellard S; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Pokaż więcej
Źródło :
Clinical chemistry [Clin Chem] 2020 Jul 01; Vol. 66 (7), pp. 958-965.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Handsearching had best recall but poor efficiency when exporting to a bibliographic tool: case study.
Autorzy :
Cooper C; Department of Clinical, Educational and Health Psychology, University College London, London WC1E 7HB, UK. Electronic address: .
Snowsill T; Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, Devon, UK.
Worsley C; Tolley Health Economics, Buxton, UK.
Prowse A; Tolley Health Economics, Buxton, UK.
O'Mara-Eves A; EPPi Centre, University College of London, London, UK.
Greenwood H; Royal College of Psychiatrists, London, UK.
Boulton E; Tolley Health Economics, Buxton, UK.
Strickson A; Tolley Health Economics, Buxton, UK.
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2020 Jul; Vol. 123, pp. 39-48. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Autorzy :
Kang YJ; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Killen J; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Caruana M; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Simms K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Taylor N; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Frayling IM; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom.; Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom.
Snowsill T; University of Exeter Medical School, Exeter, United Kingdom.
Huxley N; Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC.
Coupe VM; Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Hughes S; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Freeman V; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Boussioutas A; University of Melbourne, Melbourne, VIC.; Royal Melbourne Hospital, Melbourne, VIC.
Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Ward RL; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Mitchell G; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Macrae FA; Royal Melbourne Hospital, Melbourne, VIC.
Canfell K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2020 Feb; Vol. 212 (2), pp. 72-81. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonoscopy/*statistics & numerical data
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Cost-Benefit Analysis/*statistics & numerical data
Genetic Testing/*economics
Aged ; Australia/epidemiology ; Colonoscopy/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/mortality ; Female ; Humans ; Immunohistochemistry/economics ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.
Autorzy :
Yang H; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Robinson S; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Griffin E; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Peters J; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.; 2Exeter Test Group, University of Exeter Medical School, Exeter, UK.
Hyde C; 1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.; 2Exeter Test Group, University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Diagnostic and prognostic research [Diagn Progn Res] 2019 Nov 28; Vol. 3, pp. 23. Date of Electronic Publication: 2019 Nov 28 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A New Method for Model-Based Health Economic Evaluation Utilizing and Extending Moment-Generating Functions.
Autorzy :
Snowsill T; Health Economics Group, University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Medical decision making : an international journal of the Society for Medical Decision Making [Med Decis Making] 2019 Jul; Vol. 39 (5), pp. 523-539. Date of Electronic Publication: 2019 Jul 18.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Economic*
Economics, Medical/*statistics & numerical data
Humans ; Markov Chains ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Yang H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Griffin E; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Robinson S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.; Exeter Test Group, University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2018 Nov; Vol. 22 (69), pp. 1-276.
Typ publikacji :
Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Early Detection of Cancer*
Mass Screening*
Tomography, X-Ray Computed*
Lung Neoplasms/*diagnostic imaging
Humans ; Quality-Adjusted Life Years ; Technology Assessment, Biomedical ; Treatment Outcome
Raport
Tytuł :
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.
Autorzy :
Tikhonova IA; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK. .
Huxley N; Monash University, Melbourne, VIC, Australia.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Crathorne L; Roboleo Ltd, York, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Pokaż więcej
Źródło :
PharmacoEconomics [Pharmacoeconomics] 2018 Jul; Vol. 36 (7), pp. 837-851.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*economics
Camptothecin/*analogs & derivatives
Cetuximab/*economics
Colonic Neoplasms/*economics
Colorectal Neoplasms/*economics
Cost-Benefit Analysis/*statistics & numerical data
Panitumumab/*economics
Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Camptothecin/economics ; Camptothecin/therapeutic use ; Cetuximab/therapeutic use ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/genetics ; Colonic Neoplasms/secondary ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/secondary ; Female ; Fluorouracil/economics ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/economics ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Models, Economic ; Organoplatinum Compounds/economics ; Organoplatinum Compounds/therapeutic use ; Panitumumab/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic/statistics & numerical data ; Survival Analysis
SCR Protocol :
Folfox protocol; IFL protocol
Czasopismo naukowe
Tytuł :
A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.
Autorzy :
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK. .
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Frayling IM; Institute of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2017 Dec 08; Vol. 17 (1), pp. 836. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Microsatellite Instability*
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Molecular Diagnostic Techniques/*methods
Molecular Diagnostic Techniques/*standards
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Young Adult
Czasopismo naukowe
Tytuł :
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Frayling IM; Institute of Cancer and Genetics, University Hospital of Wales, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Sep; Vol. 21 (51), pp. 1-238.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Genetic Testing*/economics
Genetic Testing*/methods
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; DNA Mismatch Repair ; Endometrial Neoplasms ; England ; Female ; Humans ; Microsatellite Instability ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Tikhonova I; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Jun; Vol. 21 (38), pp. 1-294.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Treatment Outcome*
Antibodies, Monoclonal/*administration & dosage
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*administration & dosage
Antineoplastic Agents/*economics
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Agents, Immunological/*economics
Cetuximab/*administration & dosage
Cetuximab/*economics
Colorectal Neoplasms/*drug therapy
Neoplasm Metastasis/*drug therapy
Cost-Benefit Analysis ; Female ; Humans ; Male ; Panitumumab ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Autorzy :
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Moore J; Exeter Kidney Unit, Royal Devon and Exeter Foundation Trust Hospital, Exeter, UK.
Allwood M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (62), pp. 1-594.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/economics ; Abatacept/therapeutic use ; Antibodies, Monoclonal ; Antilymphocyte Serum ; Basiliximab ; Bayes Theorem ; Cost-Benefit Analysis ; Everolimus/economics ; Everolimus/therapeutic use ; Graft Rejection/prevention & control ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/economics ; Mycophenolic Acid/therapeutic use ; Quality of Life ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Recombinant Fusion Proteins ; Sirolimus/economics ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Autorzy :
Haasova M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Dudley J; Department of Paediatric Nephrology, Bristol Royal Hospital for Children (University Hospitals Bristol NHS Foundation Trust), Bristol, UK.
Marks S; Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (61), pp. 1-324.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/therapeutic use ; Antibodies, Monoclonal/economics ; Antibodies, Monoclonal/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Azathioprine/economics ; Azathioprine/therapeutic use ; Basiliximab ; Child ; Clinical Trials as Topic ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Everolimus/therapeutic use ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/therapeutic use ; Recombinant Fusion Proteins/economics ; Recombinant Fusion Proteins/therapeutic use ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Autorzy :
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Medina-Lara A; University of Exeter Medical School, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter Hospital, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Feb; Vol. 20 (13), pp. 1-588, v-vi.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Technology Assessment, Biomedical*
Anemia/*drug therapy
Hematinics/*therapeutic use
Neoplasms/*drug therapy
Anemia/economics ; Anemia/etiology ; Hematinics/economics ; Humans ; Models, Economic ; Neoplasms/economics ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Autorzy :
Snowsill T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. t.m.snowsill@exeter.ac.uk.
Huxley N; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Hoyle M; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Jones-Hughes T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. t..
Coelho H; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Cooper C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Frayling I; Institute of Cancer & Genetics, Cardiff University, Cardiff, UK. .
Hyde C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2015 Apr 25; Vol. 15, pp. 313. Date of Electronic Publication: 2015 Apr 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Age of Onset ; Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; DNA Mutational Analysis ; Decision Making, Computer-Assisted ; Female ; Humans ; Male ; Middle Aged ; Models, Economic ; Molecular Diagnostic Techniques/economics ; Quality-Adjusted Life Years ; Risk ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Meng Y; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Mújica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2015 Jan; Vol. 19 (2), pp. v-xxv, 1-215.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Breast Neoplasms/*pathology
Lymph Nodes/*pathology
Nucleic Acid Amplification Techniques/*methods
Axilla ; Cost-Benefit Analysis ; England ; Humans ; Intraoperative Period ; Lymphatic Metastasis ; Quality of Life ; Quality-Adjusted Life Years ; Sensitivity and Specificity ; Sentinel Lymph Node Biopsy ; State Medicine
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Frayling I; Institute of Medical Genetics, Cardiff University, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2014 Sep; Vol. 18 (58), pp. 1-406.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; Genetic Testing/economics ; Genetic Testing/methods ; Humans ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies